Hologic (HOLX) Tops Q3 EPS by 21c

Hologic (NASDAQ: HOLX) reported Q3 EPS of $1.33, $0.21 better than the analyst estimate of $1.12. Revenue for the quarter came in at $1.17 billion versus the consensus estimate of $1.04 billion.

“Hologic posted very strong financial results in our third fiscal quarter, with both revenue and EPS growth exceeding our guidance,” said Steve MacMillan, the Company’s chairman, president and chief executive officer. “Our base businesses showed strong momentum and we continued to make a big difference against the COVID pandemic. And we used our strong cash flows to strengthen the Company for the future by finalizing the Mobidiag acquisition.”

GUIDANCE:

Hologic sees Q4 2021 EPS of $0.92-$1.00, versus the consensus of $1.13. Hologic sees Q4 2021 revenue of $1-1.04 billion, versus the consensus of $1.04 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
• Mohawk Industries (MHK) Tops Q1 EPS by 19c